Small Molecule API CDMO Benchmarking (10th Ed.)

Report Overview

ISR’s Small Molecule API Contract Manufacturing Quality Benchmarking (10th Edition) report has a wealth of information, created with two goals in mind: to help biopharmaceutical companies make more informed CDMO decisions, and to help CDMOs optimize operational and marketing strategies.

This report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CDMO service quality across a series of 23 performance attributes specific to outsourced drug substance manufacturing. In this Consumer Reports-style analysis, ISR presents data on 399 service encounters from 127 respondents who have been involved in outsourced small molecule API projects in the past 18 months.

What you will learn:

Drug Developers:

• Make a more educated purchase of CDMO services by understanding which manufacturers best fit your company’s needs in addition to how individual CDMOs have measured up to sponsor-peer expectations on similar projects
• Uncover which CDMO attributes drive outsourcing partner selection for small molecule API manufacturing as well as which CMO attributes have gained importance over the past 12 months among industry peers
• Gain insight into CDMO customer loyalty, an index based on customer satisfaction, willingness to recommend, and likelihood to use again, along with verbatim responses from customers regarding their experience

Contract Manufacturers:

• Understand your company’s competitive positioning as well as delivery strengths and weaknesses and use this information to develop targeted messaging on true areas of strength
• Compare your company’s performance against its competitors across 23 performance metrics specific to outsourced drug substance manufacturing and related services
• Gain insight into drug developers’ outsourcing preferences and practices when it comes to CDMO selection and CDMO preference for outsourced small molecule API manufacturing

Major Sections:

• Outsourcing Philosophies & Practices
• CDMO Selection Drivers
• CDMO Perceptions & Interactions
• CDMO Performance & Loyalty
• The Small Molecule API CDMO Competitive Landscape
• Company Service Quality Profiles
• Appendix
• CDMO Drill-Downs
• Demographics

Included Providers:

• AbbVie Contract Manufacturing
• AGC Pharma Chemicals
• Ajinomoto Bio-Pharma Services
• Almac
• Aragen
• Ardena
• Asymchem
• Axplora
• Bachem
• BioDuro
• Cambrex
• Carbogen Amcis
• ChemCon
• Corden Pharma
• Curia
• Esteve
• EUROAPI
• Evonik
• Evotec
• Fareva
• Fermion
• Grace FCMS
• GSK Contract Manufacturing
• Hetero
• Hovione
• Lonza
• MilliporeSigma
• Nanoform
• Neuland
• Olon
• Patheon, by Thermo Fisher Scientific
• Pfizer CentreOne
• Piramal Pharma Solutions
• PROCOS
• Quotient Sciences
• Sai Life Sciences
• SEQENS
• Siegfried
• SK Pharmteco
• Sterling Pharma Solutions
• Syngene
• WuXi STA
• Yuhan CDMO

Companies listed in bold print have been reviewed by 10 or more respondents. These providers have detailed company service quality profiles and are included in an in-depth performance analysis.